← SynDRA
FLOXURIDINE
SynDRA canonical compound SYN0002561 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | TYMS |
| Mechanism of action | DNA synthesis inhibitor |
| Indication | colorectal cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- TYMS INHIBITOR
- thymidylate synthase inhibitor
- DNA synthesis inhibitor
- Candi TMP1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCC5
- MAPK1
- OPRD1
- NR3C1
- NPY2R
- NPY1R
- NFE2L2
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAOB
- ACHE
- MAOA
- LMNA
- LCK
- KDR
- KCNH2
- IDH1
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- OPRK1
- OPRM1
- PDE3A
- PDE4A
- TYMP
- TDP1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SMN1
- SLCO1B3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- A4
- ATXN2
- TF65
- SYK
- PARP1
- NSD2
- NFKB1
- NF2L2
- NCOA3
- NCOA1
- MMP14
- KSYK
- KLF5
- JAK2
- IFNG
- IDHC
- ESRRA
- TP53
Drug classes
- Antimetabolites
- Antimetabolites, Antineoplastic
- Antineoplastic Agents
- Noxae
- Antimetabolite
ATC classes
Cross-references
Synonyms
- FUDR
- floxuridin
- 5-Fluorouracil deoxyriboside
- 5-Fluorodeoxyuridine
- Floxuridina
- 5-fluoro-2-deoxyuridine
- 5-fudr
- Fluoruridine deoxyribose
- Fudr
- NSC-27640
- F.u.d.r.
- 2'-Deoxy-5-fluorouridine
- 5 Fluorodeoxyuridine
- Fluorodeoxyuridine
- Floxuridin
- Deoxyfluorouridine
- 5-Fluoro-2'-deoxyuridine
- FdUrd
- Floxuridinum
- Floxiridina
- 5FdU
- 5-Fluoro-2-desoxyuridine
- Floxuridinum [INN-Latin]
- FDUR
- Floxiridina [INN-Spanish]
- beta-5-Fluoro-2'-deoxyuridine
- 5-Fluoro-2-deoxyuridine
- 5-FdUrd
- Sterile fudr (TN)
- Floxuridine/5-fluorouracil
- 5-Fluorouracil 2'-deoxyriboside
- 1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil
- Uridine, 2'-deoxy-5-fluoro
- NSC 27640
- 1beta-D-2'-Deoxyribofuranosyl-5-flurouracil
- 1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil
- 5-FUDR
Look up FLOXURIDINE in the interactive SynDRA portal →